PAROLINI, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 3.293
AS - Asia 2.835
NA - Nord America 2.816
SA - Sud America 261
AF - Africa 65
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.289
Nazione #
US - Stati Uniti d'America 2.685
CN - Cina 986
GB - Regno Unito 854
SG - Singapore 812
DE - Germania 457
IT - Italia 457
SE - Svezia 411
RU - Federazione Russa 277
HK - Hong Kong 248
BR - Brasile 189
FR - Francia 189
NL - Olanda 173
IN - India 159
UA - Ucraina 136
VN - Vietnam 136
BD - Bangladesh 129
TR - Turchia 117
KR - Corea 93
CA - Canada 88
FI - Finlandia 84
IE - Irlanda 79
EU - Europa 71
PL - Polonia 62
JP - Giappone 36
CI - Costa d'Avorio 33
CO - Colombia 31
GR - Grecia 22
ID - Indonesia 22
BE - Belgio 21
MX - Messico 21
IQ - Iraq 16
RO - Romania 16
AR - Argentina 15
ES - Italia 14
AU - Australia 12
IL - Israele 12
PH - Filippine 11
PK - Pakistan 9
CL - Cile 8
UZ - Uzbekistan 8
CH - Svizzera 7
TW - Taiwan 7
AT - Austria 6
CR - Costa Rica 6
IR - Iran 6
MA - Marocco 6
PE - Perù 6
ZA - Sudafrica 6
DK - Danimarca 5
JM - Giamaica 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
DZ - Algeria 3
EC - Ecuador 3
JO - Giordania 3
NP - Nepal 3
SI - Slovenia 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
HN - Honduras 2
LB - Libano 2
LY - Libia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BJ - Benin 1
BM - Bermuda 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
Totale 9.351
Città #
Southend 771
Singapore 479
Chandler 264
Ashburn 263
Hong Kong 239
Beijing 221
San Jose 155
Milan 144
Seattle 141
Wilmington 110
Princeton 106
Santa Clara 103
Frankfurt am Main 101
Jacksonville 96
Dublin 78
Mountain View 78
Council Bluffs 74
Nanjing 69
Dallas 68
Boardman 66
Redmond 66
Ann Arbor 63
Los Angeles 61
Bengaluru 59
Warsaw 59
Toronto 58
Moscow 55
Munich 53
New York 47
Phoenix 46
Sakarya 46
Lauterbourg 43
Buffalo 40
Hanoi 37
Ho Chi Minh City 37
Woodbridge 37
Des Moines 36
Helsinki 36
Shanghai 34
Abidjan 33
Medford 33
Shenyang 32
Fairfield 30
Dearborn 29
Serra 29
Andover 28
Bogotá 26
Jinan 24
Rome 24
Tianjin 24
Guangzhou 23
Tokyo 22
Athens 20
Eitensheim 20
Somerville 20
São Paulo 20
Changsha 19
Hebei 19
Roxbury 19
Brussels 17
Hefei 16
Houston 16
Nanchang 16
Bitonto 15
Chicago 15
Fuzhou 15
Quanzhou 15
Cangzhou 13
Columbus 12
Hangzhou 12
Mumbai 12
San Diego 11
Zhengzhou 11
Cambridge 10
Falkenstein 10
Hamburg 10
Jakarta 10
Redwood City 10
Rishon Le Zion 10
The Dalles 10
Da Nang 9
Nuremberg 9
Odernheim 9
Seoul 9
Clifton 8
Falls Church 8
Kiez 8
Montreal 8
Amsterdam 7
Auburn Hills 7
Haikou 7
Kunming 7
Noginsk 7
Wuhan 7
Xian 7
Berlin 6
Grafing 6
Haiphong 6
Hanover 6
London 6
Totale 5.446
Nome #
CALCIUM HANDLING IN MYOGENIC PROGENITORS AND SKELETAL MYOBLASTS: THE ROLE OF CD20 407
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy 384
Modificazione genica di cellule staminali distrofiche allo scopo di trapianto autologo nella distrofia muscolare di Duchenne 338
Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle 288
T and b lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse 284
Correlation of circulanting CD133+ progenitor subclasses with a Mild phenotype in Duchenne Muscular dystrophy patients 257
Characterization of muscle-specific expression of miRNAs in duchenne muscular dystrophy 252
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 251
VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation 238
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies 235
High Mobility group protein 3 (Hmgb3) is regulated by microRNA-206 during muscle regeneration 235
CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells 230
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 223
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 221
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy 204
Combining gene and stem cell therapy in the treatment of disferlinopaties 203
Human fetal CD133+ skeletal muscle cells expressing pericyte merkers generate muscle and endothelial cells and repair dystrophic muscle tissues. 202
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 199
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy 198
Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection 195
Cell Therapy of Muscular Dystrophy with Engineered CD133+ Cells 193
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy. 192
Cell Theraphy of Muscolar Dystrophy with Engineered CD133+Cell 192
Full-length dysferlin expression driven by engineered human dystrophic blood-derived CD133+ stem cells 192
Combining Gene and Stem Cell therapy in the Treatment of Dysferlinophaties 186
Differential Activativation of CD20-Related Signalling Pathway Results in Distinct Differentiation Behaviour of Normal and DMD Circulating CD133+ Stem Cells 182
Muscular dystrophies therapies by engineered stem cells 182
The myomiR-206 partecipate to muscle-regeneration by sculpting the chromatin through the down.regulation of the non-histone chromatin-associated protein High Mobility group protein 3 (Hmgb3) 180
Preclinical experience and perspectives of a clinical trial using cD133 stem cells 179
Muscle-specific microRNAs (mirnas) in Duchenne Muscular Distrophy (DMD). 178
Stem cells and gene therapy combination for muscular dystrophy 177
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies. 174
Hmgb3 Is Regulated by MicroRNA-206 during Muscle Regeneration 174
Muscle-specific microRNAs (mirnas) in Duchenne Muscular Distrophy (DMD). 171
Stem Cell Therapies to Treat Muscular Dystrophy : Progress to Date 169
Absence of T and B lymphocytes enhances skeletal muscle regeneration and ameliorates dystrophic pathology in dysferlin deficient animal model 168
Autologous transplantation of engineered muscle-derived CD133+ stem cells 167
Myogenic differentiation potential of CD133+ stem cells isolated from various sources 167
Combining Stem Cells and Exon-Skipping and Approch to Treat Muscular Dystrophies 164
Differential Activation of CD20-related Signaling Pathways Results in distinct differentiation behaviour of normal and DMD circulating CD133+ Stem Cells 163
MiRNAs dysregulation of Single Muscle Fibers in Duchenne Muscular Dystrophy 156
Human Fetal CD133+ Muscle Cells Expressing Perycite Markers Repair Dystrophic Muscle Tissue. 156
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 154
Abundance of Circulating Progenitors with Myo-Endothelial Potential Correlates with a Mild Phenotype in Patients Affected by Duchnne Muscular Dystrophy 154
Stem cell therapy of muscular dystrophies using exon skipping approach in GRMD dogs 145
MicroRNA-206 is Upregulated in an Animal Model of Duchenne Muscular Dystrophy 136
MiRNAs Dysregulation of Single muscle fibers in Duchenne Muscular Dystrophy 134
Frattura spontanea di cateteri di sistemi venosi totalmente impiantabili (SVTI) 122
Combining gene and stem cell therapy in the treatment of dysferlinophaties 1
T- and B-lymphocytes depletion has a great effect on the fibrosis of the dystrophic skeletal muscles in the scid/mdx mouse 1
Stem cell therapy of muscular dystrophies using exon skipping approach in GRMD dogs 1
Totale 9.754
Categoria #
all - tutte 25.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022621 58 23 10 35 23 53 41 20 92 37 76 153
2022/2023955 137 114 85 111 101 160 10 69 126 6 26 10
2023/2024506 15 40 24 46 159 28 26 21 4 34 40 69
2024/20251.268 54 81 28 182 130 35 64 125 39 155 91 284
2025/20262.536 267 142 216 183 233 179 339 108 246 217 221 185
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 9.754